Aminocin (Amikacin Sulphate)
Aminocin is a highly effective aminoglycoside antibiotic indicated for the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria. It is widely recognized as the drug of choice for various surgical infections and severe systemic conditions.
Clinical cure rates in pneumonia and bronchitis have been shown to be as high as 92%, making Aminocin a reliable choice for respiratory tract infections, as well as infections of the skin, bone, joint, and intra-abdominal areas.
Aminocin
Amikacin Sulphate BP
Broad-spectrum bactericidal activity against many Gram-negative bacteria.
Highly stable against most aminoglycoside-inactivating enzymes.
Effective clinical cure rate (up to 92% in respiratory infections).
Suitable for both Intramuscular (IM) and Intravenous (IV) administration.
Standard choice for empirical therapy in severe infections.